Quant Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 17-05-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 3.14 0.49 56.63 14.62 22.82 15.30

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 53.51 14.95 25.23 1.82 7,132.82
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 56.82 16.22 26.20 1.95 3,834.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 51.56 16.39 25.53 2.01 2,667.21
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 50.59 16.65 27.11 2.00 2,343.94
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 49.87 14.21 25.56 1.99 2,236.01

Fund Holdings as on 30-April-2024

  • Reliance Industries Limited

  • Aurobindo Pharma Limited

  • Poly Medicure Limited

  • Life Insurance Corporation Of India

  • Glaxosmithkline Pharmaceuticals Ltd

  • Indraprastha Medical Corporation Limited

  • Jubilant Pharmova Limited

  • Kovai Medical Center & Hospital Ltd.

  • Gujarat Themis Biosyn Ltd

  • Dishman Carbogen Amcis Ltd

  • SMS Pharmaceuticals Limited

  • Sequent Scientific Limited

  • INDOCO REMEDIES LIMITED

  • Suven Life Sciences Ltd.

  • Granules India Limited

  • Aarti Pharmalabs Limited

  • AstraZeneca Pharma India Ltd

  • BROOKS Laboratories Limited

  • 91 Days Treasury Bill 02-May-2024

  • Kopran Limited

  • TREPS 02-May-2024 DEPO 10

  • NCA-NET CURRENT ASSETS

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Refineries

  • Medical Equipment/Supplies/Accessories

  • Insurance

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹279.47 crore. Quant Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of Quant Healthcare Fund ended up ₹0.25(1.82%)yesterday to ₹13.8526.

Among its top 3 holdings the fund has exposure to Reliance Industries Limited, and

The Quant Healthcare Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

11, Scindia House, Connaught Circus, New Delhi - 110 001

011-43587415, 43587420
help@quant.in
011-43587432